Test-Negative Case-Control Study
Cross-source consensus on Test-Negative Case-Control Study from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Benefits
Evidence quality
Other
Highlighted claims
- The study uses a test-negative case-control design to evaluate real-world vaccine effectiveness. — Real-world effectiveness of perinatal RSV immunoprophylaxis: protocol for a test-negative case–control study
- Cases are infants with acute respiratory illness who test positive for RSV by PCR. — Real-world effectiveness of perinatal RSV immunoprophylaxis: protocol for a test-negative case–control study
- Controls are infants meeting the same acute respiratory illness criteria who test negative for RSV. — Real-world effectiveness of perinatal RSV immunoprophylaxis: protocol for a test-negative case–control study
- Valid inference depends on accurate infection classification, similar enrolment and testing of symptomatic patients, and controls from the same source population as cases. — Real-world effectiveness of perinatal RSV immunoprophylaxis: protocol for a test-negative case–control study
- The test-negative design reduces bias from healthcare-seeking differences because cases and controls sought care for similar symptoms. — Real-world effectiveness of perinatal RSV immunoprophylaxis: protocol for a test-negative case–control study